Log In
Print this Print this

bevasiranib (formerly Cand5)

Also known as: Short interfering RNA (siRNA) targeting VEGF, bevasiranib sodium

  Manage Alerts
Collapse Summary General Information
Company RXi Pharmaceuticals Corp.
DescriptionShort interfering RNA (siRNA) targeting vascular endothelial growth factor (VEGF) mRNA
Molecular Target Vascular endothelial growth factor (VEGF) mRNA
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase III
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today